Tumor-selective catalytic nanomedicine by nanocatalyst delivery
The specific metabolism of cancer cells may allow for selective tumor therapeutics. Here, the authors show that a suitable combination of an enzyme and iron nanoparticles loaded on dendritic silica induces apoptosis of cancer cells in response to the glucose-reliant and mild acidic microenvironment.
Guardado en:
Autores principales: | Minfeng Huo, Liying Wang, Yu Chen, Jianlin Shi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5d8207be121418abae075316c2f8030 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In situ preparation of well-dispersed CuO nanocatalysts in heavy oil for catalytic aquathermolysis
por: Ming Chen, et al.
Publicado: (2019) -
Selective electroreduction of carbon dioxide to methanol on copper selenide nanocatalysts
por: Dexin Yang, et al.
Publicado: (2019) -
Direct catalytic hydrogenation of CO2 to formate over a Schiff-base-mediated gold nanocatalyst
por: Qinggang Liu, et al.
Publicado: (2017) -
Intratumoral synthesis of nano-metalchelate for tumor catalytic therapy by ligand field-enhanced coordination
por: Bowen Yang, et al.
Publicado: (2021) -
Nanomedicine in pulmonary delivery
por: Heidi M Mansour, et al.
Publicado: (2009)